Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021

Alexander Lawandi; Sarah Warner; Junfeng Sun; Cumhur Y Demirkale; Robert L Danner; Michael Klompas; Adi Gundlapalli; Deblina Datta; Aaron M Harris; Sapna Bamrah Morris; Pavithra Natarajan; Sameer S Kadri

doi:10.1093/cid/ciab671

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021

Clin Infect Dis. 2022 Apr 28;74(8):1489-1492. doi: 10.1093/cid/ciab671.

Authors

Affiliations

¹ Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
² Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
⁴ CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Abstract

In a retrospective cohort study, among 131 773 patients with previous coronavirus disease 2019 (COVID-19), reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was suspected in 253 patients (0.2%) at 238 US healthcare facilities between 1 June 2020 and 28 February 2021. Women displayed a higher cumulative reinfection risk. Healthcare burden and illness severity were similar between index and reinfection encounters.

Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Publication types

Research Support, N.I.H., Intramural

MeSH terms

COVID-19* / epidemiology
Delivery of Health Care
Female
Humans
Incidence
Reinfection
Retrospective Studies
SARS-CoV-2*